Chlamydia trachomatis and human papillomavirus coinfection: association with p16INK4a and Ki67 expression in biopsies of patients with pre-neoplastic and neoplastic lesions

Braz J Infect Dis. 2011 Mar-Apr;15(2):126-31. doi: 10.1016/s1413-8670(11)70157-x.

Abstract

The objective of this study was to identify the frequency of coinfection by human papillomavirus (HPV) and Chlamydia trachomatis (CT) in cervical lesions and relate it with immunohistochemical expression of p16INK4a and Ki67, both oncogenicity markers. A cross-sectional study with 86 women from primary care units in southern Brazil was conducted. Cervical swabs were collected for HPV-DNA and CT-DNA detection, through the polymerase chain reaction technique (PCR). The immunohistochemical analysis was performed on biopsy cervical tissue material to identify the expression of p16INK4a and Ki67 cell cycle markers. About 83 % were positive for HPV-DNA and 19% had coinfection with CT-DNA. Among coinfected women, 56% expressed p16INK4a. There was a statistically significant association between the histological grade of the lesion and Ki67 expression. All high-grade lesions, 50% of low-grade lesions and 31% of negative biopsies expressed Ki67 (p = 0.004). A total of 37% of coinfected women expressed both markers. In conclusion, although more than half of the coinfected patients have expressed p16INK4a and more than one third have expressed both markers, these results suggest no association between those variables. However, other studies involving larger samples are necessary to corroborate such findings.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Biomarkers, Tumor / analysis
  • Chlamydia Infections / complications*
  • Chlamydia Infections / diagnosis
  • Chlamydia trachomatis / isolation & purification*
  • Cross-Sectional Studies
  • Cyclin-Dependent Kinase Inhibitor p16 / analysis*
  • DNA, Bacterial / analysis
  • DNA, Viral / analysis
  • Female
  • Humans
  • Ki-67 Antigen / analysis*
  • Papillomaviridae / isolation & purification*
  • Papillomavirus Infections / complications*
  • Papillomavirus Infections / diagnosis
  • Precancerous Conditions
  • Severity of Illness Index
  • Uterine Cervical Neoplasms / diagnosis
  • Uterine Cervical Neoplasms / virology*

Substances

  • Biomarkers, Tumor
  • Cyclin-Dependent Kinase Inhibitor p16
  • DNA, Bacterial
  • DNA, Viral
  • Ki-67 Antigen